Clinical Trials
3 trialsNCT07221474 2026-05-28
INTerpath-13
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT05243355 2022-02-17
Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Qilu Hospital of Shandong University
Phase 2 Unknown
NCT03319316 2022-01-10
SOLUTION
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn